Interferon stimulated gene - ISG15 is a potential diagnostic biomarker in oral squamous cell carcinomas

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 2, 2013, Pages 1147-1150

  Laljee, Rupesh Puthenparambil ^a   Muddaiah, Sunil ^a   Salagundi, Basavaraj ^a   Cariappa, Ponappa Muckatira ^a   Indra, Adarsh Surendran ^a   Sanjay, Venkataram ^a   Ramanathan, Arvind ^b  

^a Rajiv Gandhi University of Health Sciences   (India)

^b BHARATH UNIVERSITY   (India)

Author keywords

Isg15; ISG15 expression in oral carcinoma; Over expression of ISG15; Sustained expression of ISG15

Indexed keywords

CYTOKINE; ISG15 PROTEIN, HUMAN; TUMOR MARKER; UBIQUITIN;

ARTICLE; EARLY DIAGNOSIS; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MOUTH TUMOR; PRECANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CYTOKINES; EARLY DETECTION OF CANCER; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MOUTH NEOPLASMS; PRECANCEROUS CONDITIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL; UBIQUITINS;

EID: 84877654899     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.2.1147     Document Type: Article

References (37)

1. Andersen JB, Hassel BA (2006a). The interferon regulated ubiquitin-like protein, ISG15, in tumorigenesis: Friend or foe. Cytokine and Growth Factor Reviews, 17, 411-21.
2. Andersen JB, Aaboe M, Borden EC, et al (2006b). Stage-associated overexpression of the ubiquitin-like protein, ISG15, in bladder cancer. Br J Cancer, 94, 1465-71.
3. Arellano-Garcia ME, Li R, Liu X, et al (2010). Identification of tetranectin as a potential biomarker for metastatic oral cancer. Int J Mol Sc, 11, 3106-21.
4. Bektas N, Noetzel E, Veeck J, et al (2008). The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer. Breast Cancer Res, 10, 58.
5. BlomstromDC, Fahey D, Kutny R, Korant BD, Knight Jr E (1986). Molecular characterization of the interferon-induced 15-kDa protein. Molecular cloning and nucleotide and amino acid sequence. J Biol Chem, 261, 8811-16.
6. Boddy MN, Howe K, Etkin LD, Solomon E, Freemont PS (1996). PIC 1a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia. Oncogene, 13, 971-82.
7. D'Cunha J, Knight E Jr, Haas AL, Truitt RL, Borden EC (1996). Immunoregulatory properties of ISG15, an interferon-induced cytokine. Proc Natl Acad Sci, 93, 211-15.
8. Desai SD, Haas AL, Wood LM, et al (2006). Elevated expression of isg15 in tumor cells interferes with the ubiquitin/26s proteasome pathway. Cancer Res, 66, 921-28.
9. Durfee LA, Lyon N, Seo K, Huibregtse JM (2010). The ISG15 conjugation system broadly targets newly synthesized proteins: implications for the antiviral function of ISG15. Mol Cell, 38, 722-32.
10. Ginos MA, Page GP, Michalowicz BS, et al (2004). Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck. Cancer Res, 64, 55-63.
11. Herrmann J, Lerman LO, Lerman A (2007). Ubiquitin and ubiquitin-like proteins in protein regulation. Circ Res,100, 1276-91.
12. He-Xin S, Kai Y, Xing L, Xin-Yi L, et al (2010). Positive regulation of interferon regulatory factor 3 activation by herc5 via ISG15 modificatio. Mol Cell Biol,30, 2424-36.
13. Hoek K, Rimm DL,Williams K, et al (2004). Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas. Cancer Res, 64, 5270-8.
14. Iacobuzio-Donahue CA, Maitra A, Olsen M, et al (2003). Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. Am J Pathol, 162, 1151-62.
15. Indian Genome Variation Consortium (2008). Genetic landscape of the people of India: a canvas for disease gene exploration. J Genet, 87, 3-20.
16. Kamitani T, Kito K, Nguyen HP, et al (1997). Characterization of NEDD8, a developmentally down-regulated ubiquitin-like protein. J Biol Chem, 272, 28557-62.
17. Lang-Ming C, Chien-Wei L, Kai-Ping C, et al (2009). Enhanced interferon signaling pathway in oral cancer revealed by quantitative proteome analysis of microdissected specimens using 16o/18o labeling and integrated two-dimensional LC-ESI-MALDI Tandem MS. Mol Cell Proteomics. 8, 1453-74.
18. Laurence A, Pesu M, Silvennoinen O, O'Shea J (2012). JAK kinases in health and disease: an update. Open Rheumatol J, 6, 232-44.
19. Liu YC, Pan J, Zhang C, et al (1999). A MHC-encoded ubiquitin-like protein (FAT10) binds noncovalently to the spindle assembly checkpoint protein MAD2. Proc Natl Acad Sci USA, 96, 4313-18.
20. Malakhova O, Malakhov M, Hetherington C, Zhang DE (2002). UBP43 (USP18) specifically removes ISG15 from conjugated proteins. J Biol Chem. 277, 14703-11.
21. Mangone FRR, Walder F, Maistro S et al (2010). Smad2 and Smad6 as predictors of overall survival in oral squamous cell carcinoma patients. Mol Cancer, 9, 106.
22. O'Donnell RK, Kupferman M, Wei SJ, et al (2005). Gene expression signature predicts lymphatic metastasis in squamous cell carcinoma of the oral cavity. Oncogene, 24, 1244-51.
23. Padovan E, Terracciano L, Certa U, et al (2002). Interferon stimulated gene 15 constitutively produced by melanoma cells induces e-cadherin expression on human dendritic cells. Cancer Res, 62, 3453-58.
24. Pitha-Rowe IF, Pitha PM (2007). Viral defense, carcinogenesis and ISG15: novel roles for an old ISG. Cytokine Growth Factor Rev, 18, 409-17.
25. Pitha-Rowe I, Petty WJ, Feng Q, et al (2004). Microarray analyses uncover ube1l as a candidate target gene for lung cancer chemoprevention. Cancer Res, 64, 8109-15.
26. Rajkumar T, Sabitha K, Vijayalakshmi N, et al (2011). Identification and validation of genes involved in cercival tumorigenesis. BMC Cancer, 11, 80.
27. Reis PP, Tomenson M, Cervigne NK, et al (2010). Programmed cell death 4 loss increases tumor cell invasion and is regulated by miR-21 in oral squamous cell carcinoma. Mol Cancer, 9, 238.
28. Roberts ZJ, Goutagny N, Perera PY, et al (2007). The chemotherapeutic agent DMXAA potently and specifically activates the TBK1-IRF-3 signaling axis. J Exp Med, 204, 1559-69.
29. Saintigny P, El-Naggar AK, Papadimitrakopoulou V et al (2009). DeltaNp63 overexpression, alone and in combination with other biomarkers, predicts the development of oral cancer in patients with leukoplakia. Clin Cancer Res, 15, 6284-91.
30. Saitoh T, Tun-Kyi A, Ryo A, et al (2006). Negative regulation of interferon-regulatory factor 3-dependent innate antiviral response by the prolyl isomerase Pin1. Nat Immunol, 7, 598-605.
31. Satake H, Tamura K, Furihata M, et al (2010). The ubiquitin-like molecule interferon-stimulated gene 15 is overexpressed in human prostate cancer. Oncol Rep, 23, 11-16.
32. Takeuchi T, Yokosawa H (2005). ISG15 modification of Ubc13 suppresses its ubiquitin-conjugating activity. Biochem Biophys Res Commun, 336, 9-13.
33. Tripathi SC, Matta A, Kaur J, et al (2010). Nuclear S100A7 is associated with poor prognosis in head and neck cancer. PLoS One, 5, 11939.
34. Yanai H, Negishi H, Taniguchi T (2012). The IRF family of transcription factors: inception, impact and implications in oncogenesis. Oncoimmunology, 8, 1376-86.
35. Ye H, Yu T, Temam S, et al (2008). Transcriptomic dissection of tongue squamous cell carcinoma. BMC Genomics, 9, 69.
36. Zhao C, Denison C, Huibregtse JM, Gygi S, Krug RM (2005). Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc Natl Acad Sci USA, 102, 10200-5.
37. Zou W, Papov V, Malakhova O, et al (2005). ISG15 modification of ubiquitin E2 Ubc13 disrupts its ability to form thioester bond with ubiquitin. Biochem Biophys Res Commun, 336, 61-8.